Global Immunohistochemistry Market by Products (Antibodies, Equipment, Reagents and Kits) by Applications (Diagnostics and Drug Testing) - Growth, Future Prospects & Competitive Analysis, 2022 - 2030.
The most common application of immunohistochemistry is to study and identify the site of origin of metastatic tumor when the primary site has already been identified. Technological advancement in the panel of immunostains can be helpful in resolving all diagnostic problems. Recent antibodies such as cadherin-17, SATB2, CDX-2 and villin have found application in the differential diagnosis of suspected metastatic adenocarcinoma. A strong limitation of immunohistochemistry is the number of parameters that can be detected, and the capacity of multiplexing immunohistochemistry is very limited.
For the purpose of this study, the various products studied includes antibodies, equipment, reagents, and kits. The applications are classified as diagnostics and drug testing. Antibodies are further classified as (primary antibodies, secondary antibodies). Equipment;s are categorized as (slide staining systems, tissue microarrays, tissue processing system, slide scanners and others). Reagents are further sub segmented as (histological stains, blocking sera and reagents, chromogenic substrates, fixation reagents, stabilizers, organic solvents, proteolytic enzymes and diluents). Diagnostics are further segmented as (cancer, infectious diseases, cardiovascular diseases, autoimmune diseases, diabetic mellitus, and nephrological diseases). Market size estimates and forecast of these segments for the period 2020 to 2030 are provided in terms of US$ Mn along with the respective CAGRs for the period 2022 to 2030, considering 2021 as the base year.
This report also includes qualitative assessment factors such as market dynamics (drivers, restraints and opportunities) to have a good understanding of the current and anticipated trends in the global immunohistochemistry market. Market attractiveness assessment and competitive landscape analysis by key players are also presented in the study. Furthermore, this report concludes with profiling of key market players currently enjoying prominent position in the global immunohistochemistry market. The key players profiled in this report are Abcam plc, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., BioSB, Cell Signaling Technology, Inc., Danaher Corporation, F. Hoffman La-Roche Ltd., Merck Millipore Corporation, Perkin Elmer, Inc., and Thermo Fisher Scientific, Inc.
The immunohistochemistry market is driven by factors such as rising prevalence of cancer, aging population suffering with chronic diseases and urgent requirement for novel drug discovery in cases such as multiple drug resistance bacterial infection. In addition, increasing number of diagnostic centers and increasing physician awareness regarding disease etiology will propel the deep market penetration for immunohistochemistry. In 2016, antibodies segment held the largest market share chiefly due to factors such as technological advancement in the production and development of antigen specific antibodies finding immense requirement in diagnosis and stem cell population determination etc., increasing demand for personalized medication and the recent technological advancement in biologicals for the treatment of chronic diseases.
Reagents will be the fastest growing segment throughout the forecast period 2022-2030 majorly due to factors such as rising prevalence of chronic diseases, steadily increasing diagnostic centers and public private partnership to combat life threatening diseases by setting research and development centers. The major players in immunohistochemistry market are Abcam plc, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., BioSB, Cell Signaling Technology, Inc., Danaher Corporation, F. Hoffman La-Roche Ltd., Merck Millipore Corporation, Perkin Elmer, Inc., Thermo Fisher Scientific, Inc. and other notable players.
North America was observed to be the largest market for immunohistochemistry in the base year 2021. According to the Center for Disease Control and Prevention, in 2012, about half of the American population suffered with one or more chronic health conditions. The dominance of North America is mainly attributed to the presence of key drivers such as rising prevalence of chronic disease, matured biotechnology market, increasing commercialization of the immunohistochemistry products and developed research and healthcare institutions. The market growth in Europe is mainly attributed to the rising prevalence of chronic diseases, as per the OECD/European Commission report 2016 approximately 550,000 premature deaths were reported across European Union. This factor boosts the demand for antibodies for the identification and screening of biomarkers related to chronic diseases and technological advancement in the tissue processing systems and chromogenic substrates employed for tissue sampling.
Asia Pacific was observed as the fastest-growing regional segment throughout the forecast period 2022-2030. Factors that are anticipated to propel the market growth are the increasing number of geriatric population suffering with chronic health complications, competitive market due to presence of existing major players and evolving biopharmaceutical manufacturers producing immunohistochemistry reagents and equipment in these regions, and supportive regulatory environment for immunohistochemistry products. Moreover, factors such as developing health infrastructure, expansion of research centers by pharmaceutical giants to propel deep market penetration in the untapped market of remote areas with unmet medical needs are going to fuel the rapid growth of immunohistochemistry market in Latin America, and Middle East and Africa region in the near future.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
This product will be delivered within 2 business days.
The most common application of immunohistochemistry is to study and identify the site of origin of metastatic tumor when the primary site has already been identified. Technological advancement in the panel of immunostains can be helpful in resolving all diagnostic problems. Recent antibodies such as cadherin-17, SATB2, CDX-2 and villin have found application in the differential diagnosis of suspected metastatic adenocarcinoma. A strong limitation of immunohistochemistry is the number of parameters that can be detected, and the capacity of multiplexing immunohistochemistry is very limited.
For the purpose of this study, the various products studied includes antibodies, equipment, reagents, and kits. The applications are classified as diagnostics and drug testing. Antibodies are further classified as (primary antibodies, secondary antibodies). Equipment;s are categorized as (slide staining systems, tissue microarrays, tissue processing system, slide scanners and others). Reagents are further sub segmented as (histological stains, blocking sera and reagents, chromogenic substrates, fixation reagents, stabilizers, organic solvents, proteolytic enzymes and diluents). Diagnostics are further segmented as (cancer, infectious diseases, cardiovascular diseases, autoimmune diseases, diabetic mellitus, and nephrological diseases). Market size estimates and forecast of these segments for the period 2020 to 2030 are provided in terms of US$ Mn along with the respective CAGRs for the period 2022 to 2030, considering 2021 as the base year.
This report also includes qualitative assessment factors such as market dynamics (drivers, restraints and opportunities) to have a good understanding of the current and anticipated trends in the global immunohistochemistry market. Market attractiveness assessment and competitive landscape analysis by key players are also presented in the study. Furthermore, this report concludes with profiling of key market players currently enjoying prominent position in the global immunohistochemistry market. The key players profiled in this report are Abcam plc, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., BioSB, Cell Signaling Technology, Inc., Danaher Corporation, F. Hoffman La-Roche Ltd., Merck Millipore Corporation, Perkin Elmer, Inc., and Thermo Fisher Scientific, Inc.
The immunohistochemistry market is driven by factors such as rising prevalence of cancer, aging population suffering with chronic diseases and urgent requirement for novel drug discovery in cases such as multiple drug resistance bacterial infection. In addition, increasing number of diagnostic centers and increasing physician awareness regarding disease etiology will propel the deep market penetration for immunohistochemistry. In 2016, antibodies segment held the largest market share chiefly due to factors such as technological advancement in the production and development of antigen specific antibodies finding immense requirement in diagnosis and stem cell population determination etc., increasing demand for personalized medication and the recent technological advancement in biologicals for the treatment of chronic diseases.
Reagents will be the fastest growing segment throughout the forecast period 2022-2030 majorly due to factors such as rising prevalence of chronic diseases, steadily increasing diagnostic centers and public private partnership to combat life threatening diseases by setting research and development centers. The major players in immunohistochemistry market are Abcam plc, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., BioSB, Cell Signaling Technology, Inc., Danaher Corporation, F. Hoffman La-Roche Ltd., Merck Millipore Corporation, Perkin Elmer, Inc., Thermo Fisher Scientific, Inc. and other notable players.
Application Analysis
The crucial application of immunohistochemistry is the use of antibodies being employed to study the tissue distribution of an antigen. The eukaryotic cells use histone proteins to store the DNA in the form of chromatin material, in order to understand the genetic relations to the chronic diseases the antibodies can be employed to target histones. Immunohistochemistry is a comprehensive technique which is employed for morphological characterization of tumors and other tissue malignancies. In 2021, diagnostics segment dominated the market mainly due to factors such as rising prevalence of chronic diseases requiring immediate medical intervention and increasing public health awareness resulting into the rising number of diagnostic centers. Additionally the technological advancement in the diagnostics techniques that use antibodies to identify podocalyxin (PODXL) a trans-membrane protein involved in cell-cell interaction expressed in several cancers such as breast, prostate, testicular, colorectal and urothelial cancer. The drug testing segment is anticipated to register faster growth throughout the forecast period 2022-2030, majorly due to rising incidence of drug related adverse events and study the microbe metabolism due to increasing incidence of multiple drug resistance bacterial infection.North America was observed to be the largest market for immunohistochemistry in the base year 2021. According to the Center for Disease Control and Prevention, in 2012, about half of the American population suffered with one or more chronic health conditions. The dominance of North America is mainly attributed to the presence of key drivers such as rising prevalence of chronic disease, matured biotechnology market, increasing commercialization of the immunohistochemistry products and developed research and healthcare institutions. The market growth in Europe is mainly attributed to the rising prevalence of chronic diseases, as per the OECD/European Commission report 2016 approximately 550,000 premature deaths were reported across European Union. This factor boosts the demand for antibodies for the identification and screening of biomarkers related to chronic diseases and technological advancement in the tissue processing systems and chromogenic substrates employed for tissue sampling.
Asia Pacific was observed as the fastest-growing regional segment throughout the forecast period 2022-2030. Factors that are anticipated to propel the market growth are the increasing number of geriatric population suffering with chronic health complications, competitive market due to presence of existing major players and evolving biopharmaceutical manufacturers producing immunohistochemistry reagents and equipment in these regions, and supportive regulatory environment for immunohistochemistry products. Moreover, factors such as developing health infrastructure, expansion of research centers by pharmaceutical giants to propel deep market penetration in the untapped market of remote areas with unmet medical needs are going to fuel the rapid growth of immunohistochemistry market in Latin America, and Middle East and Africa region in the near future.
Historical & Forecast Period
This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Immunohistochemistry market are as follows:- Research and development budgets of manufacturers and government spending
- Revenues of key companies in the market segment
- Number of end users and consumption volume, price and value.
- Geographical revenues generate by countries considered in the report
- Micro and macro environment factors that are currently influencing the Immunohistochemistry market and their expected impact during the forecast period.
Market Segmentation
Product
- Antibodies
- Primary Antibodies
- Secondary Antibodies
- Equipment
- Slide Staining Systems
- Tissue Microarrays
- Tissue Processing Systems
- Slide Scanners
- Others
- Reagents
- Histological Stains
- Blocking Sera and Reagents
- Chromogenic Substrates
- Fixation Reagents
- Stabilizers
- Organic Solvents
- Proteolytic Enzymes
- Diluents
- Kits
Application
- Diagnostics
- Cancer
- Infectious Diseases
- Cardiovascular Diseases
- Autoimmune Diseases
- Diabetes Mellitus
- Nephrological Diseases
- Drug Testing
Key questions answered in this report
- What are the key micro and macro environmental factors that are impacting the growth of Immunohistochemistry market?
- What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
- Estimated forecast and market projections up to 2030.
- Which segment accounts for the fastest CAGR during the forecast period?
- Which market segment holds a larger market share and why?
- Are low and middle-income economies investing in the Immunohistochemistry market?
- Which is the largest regional market for Immunohistochemistry market?
- What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
- Which are the key trends driving Immunohistochemistry market growth?
- Who are the key competitors and what are their key strategies to enhance their market presence in the Immunohistochemistry market worldwide?
This product will be delivered within 2 business days.
Table of Contents
1. Preface1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Immunohistochemistry Market
2.2. Global Immunohistochemistry Market, By Product, 2021 (US$ Million)
2.3. Global Immunohistochemistry Market, By Application, 2021 (US$ Million)
2.4. Global Immunohistochemistry Market, By Geography, 2021 (US$ Million)
2.5. Attractive Investment Proposition by Geography, 2021
3. Immunohistochemistry Market: Competitive Analysis
3.1. Market Positioning of Key Immunohistochemistry Market Vendors
3.2. Strategies Adopted by Immunohistochemistry Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2021 Versus 2030
4. Immunohistochemistry Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Immunohistochemistry Market Value, 2020 - 2030, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
5. Immunohistochemistry Market: By Product, 2020-2030, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2021 Versus 2030
5.3. Market Segmentation
5.3.1. Antibodies
5.3.1.1. Primary Antibodies
5.3.1.2. Secondary Antibodies
5.3.2. Equipment
5.3.2.1. Slide Staining Systems
5.3.2.2. Tissue Microarrays
5.3.2.3. Tissue Processing Systems
5.3.2.4. Slide Scanners
5.3.2.5. Others
5.3.3. Reagents
5.3.3.1. Histological Stains
5.3.3.2. Blocking Sera and Reagents
5.3.3.3. Chromogenic Substrates
5.3.3.4. Fixation Reagents
5.3.3.5. Stabilizers
5.3.3.6. Organic Solvents
5.3.3.7. Proteolytic Enzymes
5.3.3.8. Diluents
5.3.4. Kits
6. Immunohistochemistry Market: By Application, 2020-2030, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2021 Versus 2030
6.3. Market Segmentation
6.3.1. Diagnostics
6.3.1.1. Cancer
6.3.1.2. Infectious Diseases
6.3.1.3. Cardiovascular Diseases
6.3.1.4. Autoimmune Diseases
6.3.1.5. Diabetes Mellitus
6.3.1.6. Nephrological Diseases
6.3.2. Drug Testing
7. North America Immunohistochemistry Market, 2020-2030, USD (Million)
7.1. Market Overview
7.2. Immunohistochemistry Market: By Product, 2020-2030, USD (Million)
7.3. Immunohistochemistry Market: By Application, 2020-2030, USD (Million)
7.4.Immunohistochemistry Market: By Region, 2020-2030, USD (Million)
7.4.1.North America
7.4.1.1. U.S.
7.4.1.1.1. Immunohistochemistry Market: By Product, 2020-2030, USD (Million)
7.4.1.1.1. Immunohistochemistry Market: By Application, 2020-2030, USD (Million)
7.4.1.2. Canada
7.4.1.2.1. Immunohistochemistry Market: By Product, 2020-2030, USD (Million)
7.4.1.2.1. Immunohistochemistry Market: By Application, 2020-2030, USD (Million)
7.4.1.3. Rest of North America
7.4.1.3.1. Immunohistochemistry Market: By Product, 2020-2030, USD (Million)
7.4.1.3.1. Immunohistochemistry Market: By Application, 2020-2030, USD (Million)
8. UK and European Union Immunohistochemistry Market, 2020-2030, USD (Million)
8.1. Market Overview
8.2. Immunohistochemistry Market: By Product, 2020-2030, USD (Million)
8.3. Immunohistochemistry Market: By Application, 2020-2030, USD (Million)
8.4.Immunohistochemistry Market: By Region, 2020-2030, USD (Million)
8.4.1.UK and European Union
8.4.1.1. UK
8.4.1.1.1. Immunohistochemistry Market: By Product, 2020-2030, USD (Million)
8.4.1.1.1. Immunohistochemistry Market: By Application, 2020-2030, USD (Million)
8.4.1.2. Germany
8.4.1.2.1. Immunohistochemistry Market: By Product, 2020-2030, USD (Million)
8.4.1.2.1. Immunohistochemistry Market: By Application, 2020-2030, USD (Million)
8.4.1.3. Spain
8.4.1.3.1. Immunohistochemistry Market: By Product, 2020-2030, USD (Million)
8.4.1.3.1. Immunohistochemistry Market: By Application, 2020-2030, USD (Million)
8.4.1.4. Italy
8.4.1.4.1. Immunohistochemistry Market: By Product, 2020-2030, USD (Million)
8.4.1.4.1. Immunohistochemistry Market: By Application, 2020-2030, USD (Million)
8.4.1.5. France
8.4.1.5.1. Immunohistochemistry Market: By Product, 2020-2030, USD (Million)
8.4.1.5.1. Immunohistochemistry Market: By Application, 2020-2030, USD (Million)
8.4.1.6. Rest of Europe
8.4.1.6.1. Immunohistochemistry Market: By Product, 2020-2030, USD (Million)
8.4.1.6.1. Immunohistochemistry Market: By Application, 2020-2030, USD (Million)
9. Asia Pacific Immunohistochemistry Market, 2020-2030, USD (Million)
9.1. Market Overview
9.2. Immunohistochemistry Market: By Product, 2020-2030, USD (Million)
9.3. Immunohistochemistry Market: By Application, 2020-2030, USD (Million)
9.4.Immunohistochemistry Market: By Region, 2020-2030, USD (Million)
9.4.1.Asia Pacific
9.4.1.1. China
9.4.1.1.1. Immunohistochemistry Market: By Product, 2020-2030, USD (Million)
9.4.1.1.1. Immunohistochemistry Market: By Application, 2020-2030, USD (Million)
9.4.1.2. Japan
9.4.1.2.1. Immunohistochemistry Market: By Product, 2020-2030, USD (Million)
9.4.1.2.1. Immunohistochemistry Market: By Application, 2020-2030, USD (Million)
9.4.1.3. India
9.4.1.3.1. Immunohistochemistry Market: By Product, 2020-2030, USD (Million)
9.4.1.3.1. Immunohistochemistry Market: By Application, 2020-2030, USD (Million)
9.4.1.4. Australia
9.4.1.4.1. Immunohistochemistry Market: By Product, 2020-2030, USD (Million)
9.4.1.4.1. Immunohistochemistry Market: By Application, 2020-2030, USD (Million)
9.4.1.5. South Korea
9.4.1.5.1. Immunohistochemistry Market: By Product, 2020-2030, USD (Million)
9.4.1.5.1. Immunohistochemistry Market: By Application, 2020-2030, USD (Million)
9.4.1.6. Rest of Asia Pacific
9.4.1.6.1. Immunohistochemistry Market: By Product, 2020-2030, USD (Million)
9.4.1.6.1. Immunohistochemistry Market: By Application, 2020-2030, USD (Million)
10. Latin America Immunohistochemistry Market, 2020-2030, USD (Million)
10.1. Market Overview
10.2. Immunohistochemistry Market: By Product, 2020-2030, USD (Million)
10.3. Immunohistochemistry Market: By Application, 2020-2030, USD (Million)
10.4.Immunohistochemistry Market: By Region, 2020-2030, USD (Million)
10.4.1.Latin America
10.4.1.1. Brazil
10.4.1.1.1. Immunohistochemistry Market: By Product, 2020-2030, USD (Million)
10.4.1.1.1. Immunohistochemistry Market: By Application, 2020-2030, USD (Million)
10.4.1.2. Mexico
10.4.1.2.1. Immunohistochemistry Market: By Product, 2020-2030, USD (Million)
10.4.1.2.1. Immunohistochemistry Market: By Application, 2020-2030, USD (Million)
10.4.1.3. Rest of Latin America
10.4.1.3.1. Immunohistochemistry Market: By Product, 2020-2030, USD (Million)
10.4.1.3.1. Immunohistochemistry Market: By Application, 2020-2030, USD (Million)
11. Middle East and Africa Immunohistochemistry Market, 2020-2030, USD (Million)
11.1. Market Overview
11.2. Immunohistochemistry Market: By Product, 2020-2030, USD (Million)
11.3. Immunohistochemistry Market: By Application, 2020-2030, USD (Million)
11.4.Immunohistochemistry Market: By Region, 2020-2030, USD (Million)
11.4.1.Middle East and Africa
11.4.1.1. GCC
11.4.1.1.1. Immunohistochemistry Market: By Product, 2020-2030, USD (Million)
11.4.1.1.1. Immunohistochemistry Market: By Application, 2020-2030, USD (Million)
11.4.1.2. Africa
11.4.1.2.1. Immunohistochemistry Market: By Product, 2020-2030, USD (Million)
11.4.1.2.1. Immunohistochemistry Market: By Application, 2020-2030, USD (Million)
11.4.1.3. Rest of Middle East and Africa
11.4.1.3.1. Immunohistochemistry Market: By Product, 2020-2030, USD (Million)
11.4.1.3.1. Immunohistochemistry Market: By Application, 2020-2030, USD (Million)
12. Company Profile
12.1. Abcam plc.
12.1.1. Company Overview
12.1.2. Financial Performance
12.1.3. Product Portfolio
12.1.4. Strategic Initiatives
12.2. Agilent Technologies, Inc.
12.2.1. Company Overview
12.2.2. Financial Performance
12.2.3. Product Portfolio
12.2.4. Strategic Initiatives
12.3. Bio-Rad Laboratories, Inc.
12.3.1. Company Overview
12.3.2. Financial Performance
12.3.3. Product Portfolio
12.3.4. Strategic Initiatives
12.4. BioSB
12.4.1. Company Overview
12.4.2. Financial Performance
12.4.3. Product Portfolio
12.4.4. Strategic Initiatives
12.5. Cell Signaling Technology, Inc.
12.5.1. Company Overview
12.5.2. Financial Performance
12.5.3. Product Portfolio
12.5.4. Strategic Initiatives
12.6. Danaher Corporation
12.6.1. Company Overview
12.6.2. Financial Performance
12.6.3. Product Portfolio
12.6.4. Strategic Initiatives
12.7. F.Hoffman La-Roche Ltd
12.7.1. Company Overview
12.7.2. Financial Performance
12.7.3. Product Portfolio
12.7.4. Strategic Initiatives
12.8. Merck Millipore Corporation
12.8.1. Company Overview
12.8.2. Financial Performance
12.8.3. Product Portfolio
12.8.4. Strategic Initiatives
12.9. Perkin Elmer, Inc.
12.9.1. Company Overview
12.9.2. Financial Performance
12.9.3. Product Portfolio
12.9.4. Strategic Initiatives
12.10. Thermo Fisher Scientific, Inc.
12.10.1. Company Overview
12.10.2. Financial Performance
12.10.3. Product Portfolio
12.10.4. Strategic Initiatives
12.11. Other Notable Players
12.11.1. Company Overview
12.11.2. Financial Performance
12.11.3. Product Portfolio
12.11.4. Strategic Initiatives
List of Figures
Figure 1 Global Immunohistochemistry Market: Market Coverage
Figure 2 Research Methodology and Data Sources
Figure 3 Market Size Estimation - Top Down & Bottom-Up Approach
Figure 4 Global Immunohistochemistry Market: Quality Assurance
Figure 5 Global Immunohistochemistry Market, By Product, 2021
Figure 6 Global Immunohistochemistry Market, By Application, 2021
Figure 7 Global Immunohistochemistry Market, By Geography, 2021
Figure 8 Market Geographical Opportunity Matrix - Global Immunohistochemistry Market, 2021
Figure 9 Market Positioning of Key Immunohistochemistry Market Players, 2021
Figure 10 Global Immunohistochemistry Market - Tier Analysis - Percentage of Revenues by Tier Level, 2021 Versus 2030
Figure 11 Global Immunohistochemistry Market, By Product, 2021 Vs 2030, %
Figure 12 Global Immunohistochemistry Market, By Application, 2021 Vs 2030, %
Figure 13 U.S. Immunohistochemistry Market (US$ Million), 2020 - 2030
Figure 14 Canada Immunohistochemistry Market (US$ Million), 2020 - 2030
Figure 15 Rest of North America Immunohistochemistry Market (US$ Million), 2020 - 2030
Figure 16 UK Immunohistochemistry Market (US$ Million), 2020 - 2030
Figure 17 Germany Immunohistochemistry Market (US$ Million), 2020 - 2030
Figure 18 Spain Immunohistochemistry Market (US$ Million), 2020 - 2030
Figure 19 Italy Immunohistochemistry Market (US$ Million), 2020 - 2030
Figure 20 France Immunohistochemistry Market (US$ Million), 2020 - 2030
Figure 21 Rest of Europe Immunohistochemistry Market (US$ Million), 2020 - 2030
Figure 22 China Immunohistochemistry Market (US$ Million), 2020 - 2030
Figure 23 Japan Immunohistochemistry Market (US$ Million), 2020 - 2030
Figure 24 India Immunohistochemistry Market (US$ Million), 2020 - 2030
Figure 25 Australia Immunohistochemistry Market (US$ Million), 2020 - 2030
Figure 26 South Korea Immunohistochemistry Market (US$ Million), 2020 - 2030
Figure 27 Rest of Asia Immunohistochemistry Market (US$ Million), 2020 - 2030
Figure 28 Brazil Immunohistochemistry Market (US$ Million), 2020 - 2030
Figure 29 Mexico Immunohistochemistry Market (US$ Million), 2020 - 2030
Figure 30 Rest of Latin America Immunohistochemistry Market (US$ Million), 2020 - 2030
Figure 31 GCC Immunohistochemistry Market (US$ Million), 2020 - 2030
Figure 32 Africa Immunohistochemistry Market (US$ Million), 2020 - 2030
Figure 33 Rest of Middle East and Africa Immunohistochemistry Market (US$ Million), 2020 - 2030
List of Tables
Table 1 Global Immunohistochemistry Market By Product, 2020-2030, USD (Million)
Table 2 Global Immunohistochemistry Market By Antibodies, 2020-2030, USD (Million)
Table 3 Global Immunohistochemistry Market By Equipment, 2020-2030, USD (Million)
Table 4 Global Immunohistochemistry Market By Reagents, 2020-2030, USD (Million)
Table 5 Global Immunohistochemistry Market By Application, 2020-2030, USD (Million)
Table 6 Global Immunohistochemistry Market By Diagnostics, 2020-2030, USD (Million)
Table 7 North America Immunohistochemistry Market By Product, 2020-2030, USD (Million)
Table 8 North America Immunohistochemistry Market By Antibodies, 2020-2030, USD (Million)
Table 9 North America Immunohistochemistry Market By Equipment, 2020-2030, USD (Million)
Table 10 North America Immunohistochemistry Market By Reagents, 2020-2030, USD (Million)
Table 11 North America Immunohistochemistry Market By Application, 2020-2030, USD (Million)
Table 12 North America Immunohistochemistry Market By Diagnostics, 2020-2030, USD (Million)
Table 13 U.S. Immunohistochemistry Market By Product, 2020-2030, USD (Million)
Table 14 U.S. Immunohistochemistry Market By Antibodies, 2020-2030, USD (Million)
Table 15 U.S. Immunohistochemistry Market By Equipment, 2020-2030, USD (Million)
Table 16 U.S. Immunohistochemistry Market By Reagents, 2020-2030, USD (Million)
Table 17 U.S. Immunohistochemistry Market By Application, 2020-2030, USD (Million)
Table 18 U.S. Immunohistochemistry Market By Diagnostics, 2020-2030, USD (Million)
Table 19 Canada Immunohistochemistry Market By Product, 2020-2030, USD (Million)
Table 20 Canada Immunohistochemistry Market By Antibodies, 2020-2030, USD (Million)
Table 21 Canada Immunohistochemistry Market By Equipment, 2020-2030, USD (Million)
Table 22 Canada Immunohistochemistry Market By Reagents, 2020-2030, USD (Million)
Table 23 Canada Immunohistochemistry Market By Application, 2020-2030, USD (Million)
Table 24 Canada Immunohistochemistry Market By Diagnostics, 2020-2030, USD (Million)
Table 25 Rest of North America Immunohistochemistry Market By Product, 2020-2030, USD (Million)
Table 26 Rest of North America Immunohistochemistry Market By Antibodies, 2020-2030, USD (Million)
Table 27 Rest of North America Immunohistochemistry Market By Equipment, 2020-2030, USD (Million)
Table 28 Rest of North America Immunohistochemistry Market By Reagents, 2020-2030, USD (Million)
Table 29 Rest of North America Immunohistochemistry Market By Application, 2020-2030, USD (Million)
Table 30 Rest of North America Immunohistochemistry Market By Diagnostics, 2020-2030, USD (Million)
Table 31 UK and European Union Immunohistochemistry Market By Product, 2020-2030, USD (Million)
Table 32 UK and European Union Immunohistochemistry Market By Antibodies, 2020-2030, USD (Million)
Table 33 UK and European Union Immunohistochemistry Market By Equipment, 2020-2030, USD (Million)
Table 34 UK and European Union Immunohistochemistry Market By Reagents, 2020-2030, USD (Million)
Table 35 UK and European Union Immunohistochemistry Market By Application, 2020-2030, USD (Million)
Table 36 UK and European Union Immunohistochemistry Market By Diagnostics, 2020-2030, USD (Million)
Table 37 UK Immunohistochemistry Market By Product, 2020-2030, USD (Million)
Table 38 UK Immunohistochemistry Market By Antibodies, 2020-2030, USD (Million)
Table 39 UK Immunohistochemistry Market By Equipment, 2020-2030, USD (Million)
Table 40 UK Immunohistochemistry Market By Reagents, 2020-2030, USD (Million)
Table 41 UK Immunohistochemistry Market By Application, 2020-2030, USD (Million)
Table 42 UK Immunohistochemistry Market By Diagnostics, 2020-2030, USD (Million)
Table 43 Germany Immunohistochemistry Market By Product, 2020-2030, USD (Million)
Table 44 Germany Immunohistochemistry Market By Antibodies, 2020-2030, USD (Million)
Table 45 Germany Immunohistochemistry Market By Equipment, 2020-2030, USD (Million)
Table 46 Germany Immunohistochemistry Market By Reagents, 2020-2030, USD (Million)
Table 47 Germany Immunohistochemistry Market By Application, 2020-2030, USD (Million)
Table 48 Germany Immunohistochemistry Market By Diagnostics, 2020-2030, USD (Million)
Table 49 Spain Immunohistochemistry Market By Product, 2020-2030, USD (Million)
Table 50 Spain Immunohistochemistry Market By Antibodies, 2020-2030, USD (Million)
Table 51 Spain Immunohistochemistry Market By Equipment, 2020-2030, USD (Million)
Table 52 Spain Immunohistochemistry Market By Reagents, 2020-2030, USD (Million)
Table 53 Spain Immunohistochemistry Market By Application, 2020-2030, USD (Million)
Table 54 Spain Immunohistochemistry Market By Diagnostics, 2020-2030, USD (Million)
Table 55 Italy Immunohistochemistry Market By Product, 2020-2030, USD (Million)
Table 56 Italy Immunohistochemistry Market By Antibodies, 2020-2030, USD (Million)
Table 57 Italy Immunohistochemistry Market By Equipment, 2020-2030, USD (Million)
Table 58 Italy Immunohistochemistry Market By Reagents, 2020-2030, USD (Million)
Table 59 Italy Immunohistochemistry Market By Application, 2020-2030, USD (Million)
Table 60 Italy Immunohistochemistry Market By Diagnostics, 2020-2030, USD (Million)
Table 61 France Immunohistochemistry Market By Product, 2020-2030, USD (Million)
Table 62 France Immunohistochemistry Market By Antibodies, 2020-2030, USD (Million)
Table 63 France Immunohistochemistry Market By Equipment, 2020-2030, USD (Million)
Table 64 France Immunohistochemistry Market By Reagents, 2020-2030, USD (Million)
Table 65 France Immunohistochemistry Market By Application, 2020-2030, USD (Million)
Table 66 France Immunohistochemistry Market By Diagnostics, 2020-2030, USD (Million)
Table 67 Rest of Europe Immunohistochemistry Market By Product, 2020-2030, USD (Million)
Table 68 Rest of Europe Immunohistochemistry Market By Antibodies, 2020-2030, USD (Million)
Table 69 Rest of Europe Immunohistochemistry Market By Equipment, 2020-2030, USD (Million)
Table 70 Rest of Europe Immunohistochemistry Market By Reagents, 2020-2030, USD (Million)
Table 71 Rest of Europe Immunohistochemistry Market By Application, 2020-2030, USD (Million)
Table 72 Rest of Europe Immunohistochemistry Market By Diagnostics, 2020-2030, USD (Million)
Table 73 Asia Immunohistochemistry Market By Product, 2020-2030, USD (Million)
Table 74 Asia Immunohistochemistry Market By Antibodies, 2020-2030, USD (Million)
Table 75 Asia Immunohistochemistry Market By Equipment, 2020-2030, USD (Million)
Table 76 Asia Immunohistochemistry Market By Reagents, 2020-2030, USD (Million)
Table 77 Asia Immunohistochemistry Market By Application, 2020-2030, USD (Million)
Table 78 Asia Immunohistochemistry Market By Diagnostics, 2020-2030, USD (Million)
Table 79 China Immunohistochemistry Market By Product, 2020-2030, USD (Million)
Table 80 China Immunohistochemistry Market By Antibodies, 2020-2030, USD (Million)
Table 81 China Immunohistochemistry Market By Equipment, 2020-2030, USD (Million)
Table 82 China Immunohistochemistry Market By Reagents, 2020-2030, USD (Million)
Table 83 China Immunohistochemistry Market By Application, 2020-2030, USD (Million)
Table 84 China Immunohistochemistry Market By Diagnostics, 2020-2030, USD (Million)
Table 85 Japan Immunohistochemistry Market By Product, 2020-2030, USD (Million)
Table 86 Japan Immunohistochemistry Market By Antibodies, 2020-2030, USD (Million)
Table 87 Japan Immunohistochemistry Market By Equipment, 2020-2030, USD (Million)
Table 88 Japan Immunohistochemistry Market By Reagents, 2020-2030, USD (Million)
Table 89 Japan Immunohistochemistry Market By Application, 2020-2030, USD (Million)
Table 90 Japan Immunohistochemistry Market By Diagnostics, 2020-2030, USD (Million)
Table 91 India Immunohistochemistry Market By Product, 2020-2030, USD (Million)
Table 92 India Immunohistochemistry Market By Antibodies, 2020-2030, USD (Million)
Table 93 India Immunohistochemistry Market By Equipment, 2020-2030, USD (Million)
Table 94 India Immunohistochemistry Market By Reagents, 2020-2030, USD (Million)
Table 95 India Immunohistochemistry Market By Application, 2020-2030, USD (Million)
Table 96 India Immunohistochemistry Market By Diagnostics, 2020-2030, USD (Million)
Table 97 Australia Immunohistochemistry Market By Product, 2020-2030, USD (Million)
Table 98 Australia Immunohistochemistry Market By Antibodies, 2020-2030, USD (Million)
Table 99 Australia Immunohistochemistry Market By Equipment, 2020-2030, USD (Million)
Table 100 Australia Immunohistochemistry Market By Reagents, 2020-2030, USD (Million)
Table 101 Australia Immunohistochemistry Market By Application, 2020-2030, USD (Million)
Table 102 Australia Immunohistochemistry Market By Diagnostics, 2020-2030, USD (Million)
Table 103 South Korea Immunohistochemistry Market By Product, 2020-2030, USD (Million)
Table 104 South Korea Immunohistochemistry Market By Antibodies, 2020-2030, USD (Million)
Table 105 South Korea Immunohistochemistry Market By Equipment, 2020-2030, USD (Million)
Table 106 South Korea Immunohistochemistry Market By Reagents, 2020-2030, USD (Million)
Table 107 South Korea Immunohistochemistry Market By Application, 2020-2030, USD (Million)
Table 108 South Korea Immunohistochemistry Market By Diagnostics, 2020-2030, USD (Million)
Table 109 Latin America Immunohistochemistry Market By Product, 2020-2030, USD (Million)
Table 110 Latin America Immunohistochemistry Market By Antibodies, 2020-2030, USD (Million)
Table 111 Latin America Immunohistochemistry Market By Equipment, 2020-2030, USD (Million)
Table 112 Latin America Immunohistochemistry Market By Reagents, 2020-2030, USD (Million)
Table 113 Latin America Immunohistochemistry Market By Application, 2020-2030, USD (Million)
Table 114 Latin America Immunohistochemistry Market By Diagnostics, 2020-2030, USD (Million)
Table 115 Brazil Immunohistochemistry Market By Product, 2020-2030, USD (Million)
Table 116 Brazil Immunohistochemistry Market By Antibodies, 2020-2030, USD (Million)
Table 117 Brazil Immunohistochemistry Market By Equipment, 2020-2030, USD (Million)
Table 118 Brazil Immunohistochemistry Market By Reagents, 2020-2030, USD (Million)
Table 119 Brazil Immunohistochemistry Market By Application, 2020-2030, USD (Million)
Table 120 Brazil Immunohistochemistry Market By Diagnostics, 2020-2030, USD (Million)
Table 121 Mexico Immunohistochemistry Market By Product, 2020-2030, USD (Million)
Table 122 Mexico Immunohistochemistry Market By Antibodies, 2020-2030, USD (Million)
Table 123 Mexico Immunohistochemistry Market By Equipment, 2020-2030, USD (Million)
Table 124 Mexico Immunohistochemistry Market By Reagents, 2020-2030, USD (Million)
Table 125 Mexico Immunohistochemistry Market By Application, 2020-2030, USD (Million)
Table 126 Mexico Immunohistochemistry Market By Diagnostics, 2020-2030, USD (Million)
Table 127 Rest of Latin America Immunohistochemistry Market By Product, 2020-2030, USD (Million)
Table 128 Rest of Latin America Immunohistochemistry Market By Antibodies, 2020-2030, USD (Million)
Table 129 Rest of Latin America Immunohistochemistry Market By Equipment, 2020-2030, USD (Million)
Table 130 Rest of Latin America Immunohistochemistry Market By Reagents, 2020-2030, USD (Million)
Table 131 Rest of Latin America Immunohistochemistry Market By Application, 2020-2030, USD (Million)
Table 132 Rest of Latin America Immunohistochemistry Market By Diagnostics, 2020-2030, USD (Million)
Table 133 Middle East and Africa Immunohistochemistry Market By Product, 2020-2030, USD (Million)
Table 134 Middle East and Africa Immunohistochemistry Market By Antibodies, 2020-2030, USD (Million)
Table 135 Middle East and Africa Immunohistochemistry Market By Equipment, 2020-2030, USD (Million)
Table 136 Middle East and Africa Immunohistochemistry Market By Reagents, 2020-2030, USD (Million)
Table 137 Middle East and Africa Immunohistochemistry Market By Application, 2020-2030, USD (Million)
Table 138 Middle East and Africa Immunohistochemistry Market By Diagnostics, 2020-2030, USD (Million)
Table 139 GCC Immunohistochemistry Market By Product, 2020-2030, USD (Million)
Table 140 GCC Immunohistochemistry Market By Antibodies, 2020-2030, USD (Million)
Table 141 GCC Immunohistochemistry Market By Equipment, 2020-2030, USD (Million)
Table 142 GCC Immunohistochemistry Market By Reagents, 2020-2030, USD (Million)
Table 143 GCC Immunohistochemistry Market By Application, 2020-2030, USD (Million)
Table 144 GCC Immunohistochemistry Market By Diagnostics, 2020-2030, USD (Million)
Table 145 Africa Immunohistochemistry Market By Product, 2020-2030, USD (Million)
Table 146 Africa Immunohistochemistry Market By Antibodies, 2020-2030, USD (Million)
Table 147 Africa Immunohistochemistry Market By Equipment, 2020-2030, USD (Million)
Table 148 Africa Immunohistochemistry Market By Reagents, 2020-2030, USD (Million)
Table 149 Africa Immunohistochemistry Market By Application, 2020-2030, USD (Million)
Table 150 Africa Immunohistochemistry Market By Diagnostics, 2020-2030, USD (Million)
Table 151 Rest of Middle East and Africa Immunohistochemistry Market By Product, 2020-2030, USD (Million)
Table 152 Rest of Middle East and Africa Immunohistochemistry Market By Antibodies, 2020-2030, USD (Million)
Table 153 Rest of Middle East and Africa Immunohistochemistry Market By Equipment, 2020-2030, USD (Million)
Table 154 Rest of Middle East and Africa Immunohistochemistry Market By Reagents, 2020-2030, USD (Million)
Table 155 Rest of Middle East and Africa Immunohistochemistry Market By Application, 2020-2030, USD (Million)
Table 156 Rest of Middle East and Africa Immunohistochemistry Market By Diagnostics, 2020-2030, USD (Million)
Companies Mentioned
- Abcam plc
- Agilent Technologies Inc.
- Bio-Rad Laboratories Inc.
- BioSB
- Cell Signaling Technology Inc.
- Danaher Corporation
- F. Hoffman La-Roche Ltd.
- Merck Millipore Corporation
- Perkin Elmer Inc.
- Thermo Fisher Scientific Inc.
